Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Feb 03, 19:53

Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares

Vir Biotechnology Inc
Webhose 2026 Feb 02, 11:11

Did Vir's Advancing Hepatitis D Combo Program Just Shift Vir Biotechnology's (VIR) Investment Narrative? - Simply Wall St News

Vir Biotechnology Inc
Webhose 2026 Jan 29, 22:31

Chronic Hepatitis D Market Poised for Significant Growth During the Forecast Period (2025-2034) as Emerging Therapies Drive Optimism | DelveInsight

Vir Biotechnology Inc
Webhose 2026 Jan 26, 00:27

Vir Biotechnology (VIR) Is Up 24.8% After Strong SOLSTICE Combo Data In Hepatitis Delta Trial - Has The Bull Case Changed?

Vir Biotechnology Inc
Webhose 2026 Jan 23, 15:08

Vir Biotechnology (VIR) Is Up 19.4% After Strong Dual-Therapy Data in Hepatitis Delta Trial

Vir Biotechnology Inc
Webhose 2026 Jan 23, 12:15

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages

Vir Biotechnology Inc
Webhose 2026 Jan 23, 09:40

A Look At Vir Biotechnology (VIR) Valuation After New SOLSTICE Trial Data And Pipeline Updates

Vir Biotechnology Inc
Webhose 2026 Jan 21, 20:33

Vir Biotechnology (NASDAQ:VIR) Shares Up 9.9% - Should You Buy?

Vir Biotechnology Inc
Webhose 2026 Jan 20, 19:00

Reviewing Vir Biotechnology (NASDAQ:VIR) and Creative Medical Technology (NASDAQ:CELZ) - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jan 13, 22:38

Vir Biotechnology (NASDAQ:VIR) Trading 7.3% Higher - What's Next?

Vir Biotechnology Inc
Webhose 2026 Jan 13, 14:38

Vir Biotechnology (NASDAQ:VIR) Trading Up 7.3% - Should You Buy? - Daily Political

Vir Biotechnology Inc

VirBiotechnology News

Ghko B 2026 Feb 05, 16:00

Will DJT skyrocket in 2026: Is DJT stock a good long-term investment?

Ghko B 2026 Feb 05, 16:00

XRP price analysis: XRP/USD slides, what’s going on with Ripple?

Frances Wang 2026 Feb 04, 16:00

Gold price forecast: XAU/USD is above $4,900, is gold market expected to rise?

Ghko B 2026 Feb 04, 16:00

Why stock market is down: Dow DJIA slides, S&P 500 sinks, Nasdaq dips

Ghko B 2026 Feb 04, 16:00

AI stocks and investment opportunities: What are the best ai stocks to invest in?

Ghko B 2026 Feb 04, 16:00

Crypto Trend Insight 2026: XRP Price Movements and Market Analysis

Frances Wang 2026 Feb 04, 16:00

Bitcoin price prediction: Will bitcoin outperform stocks and gold in 2026?

Ghko B 2026 Feb 04, 16:00

AI stocks to watch: Why Broadcom (AVGO) stock, NVDA stock and AMD are down?

Ghko B 2026 Feb 03, 16:00

Best Retail Stocks to Buy: Amazon (AMZN) stock, WMT stock, Home Depot

Ghko B 2026 Feb 01, 16:00

ETF trading for beginners: What’s the best S&P 500 ETF to invest in 2026?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.05

Spread (%)

0.6954 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1000308928

Shares Outstanding

139125032

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.62

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Georgy Istigechev 2026 Feb 02, 16:00

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

Ghko B 2026 Jan 29, 16:00

CFD trading basics: Long position VS. short position, which is better?

Ghko B 2026 Jan 27, 16:00

What is a stochastic indicator: How to read the stochastic indicator?

Trustpilot